Page last updated: 2024-08-23

sufentanil and Pancreatic Neoplasms

sufentanil has been researched along with Pancreatic Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Cata, JP; Chen, W; Gu, J; Guo, K; Miao, C; Qu, M; Sun, Z; Wang, Y; Wu, H; Zhang, H; Zhu, X1

Trials

1 trial(s) available for sufentanil and Pancreatic Neoplasms

ArticleYear
Intraoperative lidocaine infusion in patients undergoing pancreatectomy for pancreatic cancer: a mechanistic, multicentre randomised clinical trial.
    British journal of anaesthesia, 2022, Volume: 129, Issue:2

    Topics: Anesthetics, Local; Double-Blind Method; Female; Humans; Infusions, Intravenous; Lidocaine; Male; Middle Aged; Pain, Postoperative; Pancreatectomy; Pancreatic Neoplasms; Postoperative Complications; Sufentanil

2022